# OSR HEALTH, INC. (OSRH) · Edgar & Edgarette company card

> Osr Health (OSRH) saw revenue fall 17.7% in FY2025 to $3 million, operating margin -631% against a 1.2% median for surgical & medical instruments & apparatus, equity 74.2% of assets. Every figure is from the company’s own annual report filed with the SEC.

SEC CIK 1840425 · fiscal year ended 2025-12-31 · 2 audited years read · [page](https://www.pops4.com/boards/company/OSRH) · [JSON](https://www.pops4.com/boards/company/OSRH.json)

## Figures, as filed in the 10-K

| Measure | Value |
|---|---|
| Revenue | $3M |
| Revenue growth, 1 year | -17.7% |
| Revenue growth per year | — |
| Operating margin | -631.0% (prior year -331.2%) |
| Net margin | -931.2% |
| Operating cash flow | −$4M |
| Capital spending | — |
| Free cash flow | — |
| Cash | $2M |
| Long-term debt | — |
| Total assets | $171M |
| Total equity | $127M |
| Equity ÷ assets | 74.2% |
| Return on equity | -21.3% |
| Dividend per share | — |
| Dividend years rising | — |

## Readings, computed from those figures

- Altman Z: 1.04 (distress zone)
- Piotroski F: 1 of 9 (weak)
- Beneish M: -3.1 (below the −1.78 line)
- Health Harbor boat: Old boat · three warning signs · operating cash flow was negative; operating loss: a margin of -631.0% in FY2025; revenue is hard to predict: its 80% range is ±28%

## Edgarette's reading

Exposure: revenue $2.9M (FY2025). Experience: revenue down 17.7% on the year; operating margin -631.0%, down from -331.2%. Soundness: equity 74.2% of assets, return on equity -21.3%. Credibility: 2 audited years, moderate weight. Range: 80% of past cases like this landed between $1.8M and $3.2M next year (method v3, set from 749 SEC company-years; on a year the method never saw, 83% landed inside). A statistical range, not company guidance. Against peers (60 filers, $50M+ revenue, surgical & medical instruments & apparatus): operating margin -631.0% against a 1.2% median; growth -17.7% against 11.6%.

Range logged 2026-09-20, receipt 6ca72da7a0d84bfd, status open. A statistical range, not company guidance.

## Health Watch, last 12 months

- Item 3.01 Exchange listing notice or transfer: 3, latest 2026-10-28 ([filing](https://www.sec.gov/Archives/edgar/data/1840425/000121390026113126/0001213900-26-113126-index.htm))
- Item 5.02 Director or officer change: 2, latest 2026-10-02 ([filing](https://www.sec.gov/Archives/edgar/data/1840425/000121390026106429/0001213900-26-106429-index.htm))

## Recent filings

- 8-K · filed 2026-10-28 · 3.01 Notice of Delisting or Failure to Satisfy a Listing Rule; 7.01 Regulation FD Disclosure; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1840425/000121390026113126/0001213900-26-113126-index.htm)
- 8-K · filed 2026-10-16 · 1.01 Entry into a Material Definitive Agreement; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1840425/000121390026110051/0001213900-26-110051-index.htm)
- 8-K · filed 2026-10-02 · 5.02 Departure or Election of Directors; Appointment of Officers · [filing](https://www.sec.gov/Archives/edgar/data/1840425/000121390026106429/0001213900-26-106429-index.htm)
- 8-K · filed 2026-08-28 · 8.01 Other Events · [filing](https://www.sec.gov/Archives/edgar/data/1840425/000121390026094654/0001213900-26-094654-index.htm)
- 8-K · filed 2026-08-25 · 8.01 Other Events · [filing](https://www.sec.gov/Archives/edgar/data/1840425/000121390026093379/0001213900-26-093379-index.htm)
- 8-K · filed 2026-08-19 · 3.01 Notice of Delisting or Failure to Satisfy a Listing Rule; 7.01 Regulation FD Disclosure; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1840425/000121390026091756/0001213900-26-091756-index.htm)

## Sources

- facts: https://data.sec.gov/api/xbrl/companyfacts/CIK0001840425.json
- filings: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1840425

## Cite

POPS4, Edgar & Edgarette: OSR HEALTH, INC. (OSRH) company card, from the company's own SEC filings, accessed 2026-11-04, https://www.pops4.com/boards/company/OSRH. CC BY 4.0. For a figure, add the filing URL under filings or sources.

DOI https://doi.org/10.5281/zenodo.23672509 · catalog https://www.pops4.com/boards/catalog.json · Figures as filed with the SEC. Card text CC BY 4.0, POPS4.

Reporting, not investment advice. No price targets and no trading recommendations.

Figures are as filed in audited 10-K reports and can move with restatements, acquisitions, disposals or a change in fiscal year. A range set from how past company-years turned out is not a promise about the next one, and says nothing about the share price.